S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas
Open Access
- 5 October 2004
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 91 (8) , 1515-1524
- https://doi.org/10.1038/sj.bjc.6602188
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivoOncogene, 2004
- Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylationOncogene, 2004
- Maspin – the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer – is strongly expressed in preneoplastic bronchial lesionsOncogene, 2003
- Expression of S100A2 and S100B proteins in epithelial tumors of the skinJournal of Cutaneous Pathology, 2003
- Expression profiling of primary non-small cell lung cancer for target identificationOncogene, 2002
- Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray AnalysisThe Laryngoscope, 2000
- EGF Stimulates Transcription of CaN19 (S100A2) in HaCaT Keratinocytes11The members of the European Male Aging Study (EMAS) group are listed in Appendix A.Journal of Investigative Dermatology, 1998
- Differential expression patterns ofS100a2, S100a4 andS100a6 during progression of human malignant melanomaInternational Journal of Cancer, 1997
- Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancerGenes, Chromosomes and Cancer, 1991